{
  "symbol": "SUNPHARMA.NS",
  "period": "annual",
  "data": [
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2022-03-31",
      "quarter": "Q1 2022",
      "fiscal_year": 2022,
      "revenue": 384264200000.0,
      "gross_profit": 280748800000.0,
      "operating_income": 81000200000.0,
      "ebitda": 67524100000.0,
      "net_income": 32727300000.0,
      "diluted_eps": null,
      "total_assets": 697998700000.0,
      "total_liabilities": 187337600000.0,
      "total_equity": 510661100000.0,
      "total_debt": 12903000000.0,
      "cash_and_equivalents": 45082500000.0,
      "current_assets": 350149800000.0,
      "current_liabilities": 172005500000.0,
      "operating_cash_flow": 89845400000.0,
      "investing_cash_flow": -57247400000.0,
      "financing_cash_flow": -51934600000.0,
      "free_cash_flow": 74895000000.0,
      "capex": -14950400000.0,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": 0.025267246712154107,
      "current_ratio": 2.0356895564386024,
      "operating_margin": 21.07929908640982,
      "net_profit_margin": 8.516874587848672,
      "roe": 6.408810069927003,
      "roa": 4.688733660965271,
      "debt_to_fcf_ratio": 0.1722811936711396,
      "ebitda_margin": 17.572310925660002
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2023-03-31",
      "quarter": "Q1 2023",
      "fiscal_year": 2023,
      "revenue": 432788700000.0,
      "gross_profit": 313364500000.0,
      "operating_income": 92773600000.0,
      "ebitda": 121108600000.0,
      "net_income": 84735800000.0,
      "diluted_eps": null,
      "total_assets": 807435900000.0,
      "total_liabilities": 214281200000.0,
      "total_equity": 593154700000.0,
      "total_debt": 68858700000.0,
      "cash_and_equivalents": 46237300000.0,
      "current_assets": 398833400000.0,
      "current_liabilities": 199070000000.0,
      "operating_cash_flow": 49593300000.0,
      "investing_cash_flow": -79436800000.0,
      "financing_cash_flow": 23760700000.0,
      "free_cash_flow": 28737500000.0,
      "capex": -20855800000.0,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": 0.11608893936101324,
      "current_ratio": 2.003483196865424,
      "operating_margin": 21.43623435639609,
      "net_profit_margin": 19.579023204626182,
      "roe": 14.285615540094346,
      "roa": 10.49443057956675,
      "debt_to_fcf_ratio": 2.3961270117442366,
      "ebitda_margin": 27.983309176048266
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": 477584500000.0,
      "gross_profit": 356887900000.0,
      "operating_income": 104680300000.0,
      "ebitda": 138831500000.0,
      "net_income": 95763800000.0,
      "diluted_eps": null,
      "total_assets": 854996500000.0,
      "total_liabilities": 183737100000.0,
      "total_equity": 671259400000.0,
      "total_debt": 32736700000.0,
      "cash_and_equivalents": 92856500000.0,
      "current_assets": 434749800000.0,
      "current_liabilities": 169844000000.0,
      "operating_cash_flow": 121349800000.0,
      "investing_cash_flow": -6902000000.0,
      "financing_cash_flow": -67101600000.0,
      "free_cash_flow": 99331700000.0,
      "capex": -22018100000.0,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": 0.048769074965654115,
      "current_ratio": 2.559700666493959,
      "operating_margin": 21.918697110144905,
      "net_profit_margin": 20.05169765769199,
      "roe": 14.266288114550052,
      "roa": 11.200490294404714,
      "debt_to_fcf_ratio": 0.3295695130557516,
      "ebitda_margin": 29.06951544700467
    },
    {
      "ticker": "SUNPHARMA.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 520412500000.0,
      "gross_profit": 398437400000.0,
      "operating_income": 125812000000.0,
      "ebitda": 165588800000.0,
      "net_income": 109290400000.0,
      "diluted_eps": null,
      "total_assets": 921005800000.0,
      "total_liabilities": 196146300000.0,
      "total_equity": 724859500000.0,
      "total_debt": 23621900000.0,
      "cash_and_equivalents": 102687700000.0,
      "current_assets": 526244700000.0,
      "current_liabilities": 181942100000.0,
      "operating_cash_flow": 140720900000.0,
      "investing_cash_flow": -53061600000.0,
      "financing_cash_flow": -79058200000.0,
      "free_cash_flow": 119435100000.0,
      "capex": -21285800000.0,
      "pe_ratio": 40.002293,
      "peg_ratio": null,
      "pb_ratio": 5.3778253,
      "ps_ratio": 7.6169834,
      "price_target_high": 2450.0,
      "price_target_low": 1570.0,
      "price_target_avg": 1950.6842,
      "promoter_holding": 0.55611,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 5.5,
      "splits": 2.0,
      "buybacks": 2399334970,
      "debt_to_equity": 0.032588246411890856,
      "current_ratio": 2.892374552124,
      "operating_margin": 24.175437753704994,
      "net_profit_margin": 21.00072538611198,
      "roe": 15.077459838768755,
      "roa": 11.866418213652944,
      "debt_to_fcf_ratio": 0.1977802170383748,
      "ebitda_margin": 31.818759157399178
    }
  ]
}